Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Clinical Proteomics, 2024
Multiplex proteomics identifies inflammation-related plasma biomarkers for aging and cardio-metabolic disorders

Wu S., Li Y., Zhao X. et al.

Olink Explore 3072/384Metabolic DiseasesCVDAgingPathophysiologyPatient StratificationPlasma

Frontiers in Immunology, 2024
B-cell immune dysregulation with low soluble CD22 levels in refractory seronegative myasthenia gravis

Okuzono Y., Miyakawa S., Itou T. et al.

Olink Target 96Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Genome Medicine, 2024
Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection

Luo K., Peters B., Moon J. et al.

Olink Target 96Metabolic DiseasesPathophysiologySerum

Scientific Reports, 2024
TMAO enhances TNF-α mediated fibrosis and release of inflammatory mediators from renal fibroblasts

Stefania K., Ashok K., Geena P. et al.

Olink Target 96NephrologyPathophysiologyCell Culture Supernatant

Frontiers in Immunology, 2024
Patient-derived tumoroids and proteomic signatures: tools for early drug discovery

Lê H., Deforges J., Cutolo P. et al.

Olink Target 96OncologyImmunotherapyTechnical EvaluationTissue Lysate

Frontiers in Genetics, 2024
Circulating VEGF and inflammatory bowel disease: a bidirectional mendelian randomization

Lin H., Cao B.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

European Journal of Nutrition, 2024
Meat consumption and the risk of hip fracture in women and men: two prospective Swedish cohort studies

Warensjö Lemming E., Byberg L., Höijer J. et al.

Olink Target 96Nutritional SciencePathophysiologyPlasma

Science Translational Medicine, 2024
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathology

Phan H., Tsitsiklis A., Maguire C. et al.

Olink Target 96Infectious DiseasesAgingPathophysiologySerum

Alzheimer's & Dementia, 2024
MINocyclinE to Reduce inflammation and blood‐brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double‐blind, placebo‐controlled experimental medicine trial

Brown R., Tozer D., Loubière L. et al.

Olink Target 96Neurovascular DiseasesPathophysiologySerum

Molecular Medicine, 2024
The plasma proteome differentiates the multisystem inflammatory syndrome in children (MIS-C) from children with SARS-CoV-2 negative sepsis

Patel M., Fraser D., Daley M. et al.

Olink Explore 3072/384Infectious DiseasesPatient StratificationPlasma

Nature Genetics, 2024
Integrative common and rare variant analyses provide insights into the genetic architecture of liver cirrhosis

Ghouse J., Sveinbjörnsson G., Vujkovic M. et al.

Olink Explore 3072/384HepatologyPathophysiologyPlasma

The Journal of Clinical Endocrinology & Metabolism, 2024
Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 Diabetes

Gurung R., Zheng H., Koh H. et al.

Olink Explore 3072/384Metabolic DiseasesHepatologyPathophysiologyPlasma

American Journal of Respiratory and Critical Care Medicine, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade

Wyss N., Berner F., Walter V. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPatient StratificationSerum

Diabetes Care, 2024
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes

Yao P., Iona A., Pozarickij A. et al.

Olink Explore 3072/384Metabolic DiseasesPathophysiologyPlasma

Neuro-Oncology, 2024
EDA2R reflects the acute brain response to cranial irradiation in liquid biopsies

Lastra Romero A., Seitz T., Zisiadis G. et al.

Olink Target 96 MouseOncologyNeurologyPatient StratificationPlasmaCSF

Clinica Chimica Acta, 2024
Targeted plasma proteomic analysis uncovers a high-performance biomarker panel for early diagnosis of gastric cancer

Feng T., Jie M., Deng K. et al.

Olink Explore 3072/384OncologyPatient StratificationPlasma

Journal for ImmunoTherapy of Cancer, 2024
Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

Coffey D., Osman K., Aleman A. et al.

Olink Target 96OncologyImmunotherapyPathophysiologyPlasma

JID Innovations, 2024
Dupilumab Therapy Modulates Circulating Inflammatory Mediators in Patients with Prurigo Nodularis

Bao A., Ma E., Cornman H. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

International Journal of Molecular Sciences, 2024
Circulating microRNA Profiles Identify a Patient Subgroup with High Inflammation and Severe Symptoms in Schizophrenia Experiencing Acute Psychosis

Miyano T., Mikkaichi T., Nakamura K. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Angiogenesis, 2024
Interleukin-6 drives endothelial glycocalyx damage in COVID-19 and bacterial sepsis

Drost C., Rovas A., Osiaevi I. et al.

Olink Target 96Infectious DiseasesPathophysiologyPlasma

3494 publications